Tag: biosimilars

Medications

Biologics vs Generics: Why Living Drugs Can't Be Copied Exactly

Explore why biologic drugs cannot be copied exactly like generic pills. Learn about the complex manufacturing processes, the role of biosimilars, and what this means for patient care and medication costs.

Pharmacy

Healthcare Drug Spending: How Generics Control Costs

Explore how generic drugs and biosimilars slash healthcare spending. Learn about the FDA's role, the impact of the Hatch-Waxman Act, and how to avoid the 'patent thicket'.

Medications

How Generic Drugs Save Billions in the U.S. Healthcare System

Generic drugs saved $482 billion in the U.S. in 2024 alone, making them the most powerful tool to control rising drug costs. Learn how generics and biosimilars cut spending, why brand drugs remain expensive, and what’s blocking even bigger savings.

Medications

Future of Global Generic Markets: Key Trends and Predictions for 2025-2030

The global generic drug market is growing rapidly, driven by biosimilars, emerging economies, and cost pressures. Learn the key trends shaping affordability, manufacturing, and regulation through 2030.